"Abdominal obesity" refers to having excess fat around the abdomen or belly area. It is often referred to as having a "potbelly" or "beer belly."
Full definition
However, at the end of the day, if artificial sweeteners cause increases
in abdominal obesity it looks to be secondary to modifying the diet.
A combination of characteristics, such
as abdominal obesity and hypertension, further increases the risk of these conditions.
A review of the available literature concluded that it was low estrogen, and not menopause itself, that led to
increased abdominal obesity following menopause.
Diabetes is also associated with metabolic syndrome, a medical disorder characterized
by abdominal obesity, high fasting sugars, high triglycerides, and high blood pressure.
It is said to help
reduce abdominal obesity and protect against insulin resistance thus reducing the risk of type 2 diabetes.
This could help rule out overlapping effects of lifestyle habits, he says, and show
whether abdominal obesity is a risk factor all on its own.
This review came on the heels of a 2014 study, which found that consuming whole - fat milk products reduces the risk of obesity (
especially abdominal obesity).
Good dietary management should be able to prevent the known link between artificial sweeteners and
abdominal obesity from occurring.
In scientific studies, high levels of testosterone and low levels of estrogen have been linked to lean body mass, an efficient fat - burning metabolism, and
low abdominal obesity.
One found no significant change; the other five out of six measures found significantly less weight gain, and risk
of abdominal obesity, in those eating more nuts.
Also known
as abdominal obesity or central obesity, visceral obesity refers to excess fat in the abdominal cavity that causes low - grade inflammation.
When consumed in large amounts (from added sugars, not fruit), it can lead to insulin resistance, elevated cholesterol and triglycerides and
increased abdominal obesity (14).
A 2013 study published in the Scandinavian Journal of Primary Health Care reported that men consuming high - fat dairy are at lower risk
for abdominal obesity, the most harmful type of obesity.
«It remains controversial whether overweight alone increases mortality risk, but the trends in
abdominal obesity among the overweight are concerning in light of the risks associated with increased waist circumference independent of BMI.»
«The data suggest that childhood adversity places stress on the endocrine system, leading to impairment of important hormones that can contribute to
abdominal obesity well into adulthood.»
It's not the first time we've been told of the positive health implications of quite literally watching your waistline - experts have previously suggested that a waist circumference test to
measure abdominal obesity is a more accurate predictor of heart disease and diabetes than BMI.
In the randomized controlled trial, 38 men with
abdominal obesity followed a dietary pattern high in either carbohydrates or fat, of which about half was saturated.
«Hormone changes may be involved in the development of both anxiety and
abdominal obesity because of their roles in the brain as well as in fat distribution.
It is these high levels that
cause abdominal obesity, insulin resistance (Syndrome X), hypoglycemia, type 2 diabetes and a host of other health problems.
Metabolic syndrome is a group of metabolic abnormalities,
including abdominal obesity, elevated serum triglycerides, low HDL - cholesterol, elevated blood pressure and insulin resistance.
Abdominal obesity tends to increase with weight gain and is strongly associated with various diseases such as coronary heart disease and type 2 diabetes mellitus (18).
For example, TV viewing > 3 h / day was associated with a nearly twofold increased risk of
abdominal obesity compared with TV viewing < 1 h / day.
«Although the overall trends in obesity in the United States are well appreciated and obesity prevalence may be stabilizing, our analyses highlight troublesome trends in younger adults, in women, and
in abdominal obesity prevalence, as well as persistent racial / ethnic disparities.»
Metabolic syndrome is defined
as abdominal obesity and elevated blood pressure, plasma glucose, serum triglycerides, or low high - density - lipoprotein levels and can lead to type 2 diabetes.
MCFAs and oil blends containing MCFAs have received considerable attention for their potential in
reducing abdominal obesity, which we have summarized in Table 1: Nagao and Yanagita 2010 for your convenience, based on Nagao and Yanagita (2010).
In fact, about 50 % of men and 70 % of women in the US between the ages of 50 to 79 exceed the waist circumference threshold
for abdominal obesity.
When the adiposity categories were adjusted for the same set of covariates (Table 6), individuals
with abdominal obesity had a higher mortality risk (HR, 1.25; 95 % CI, 1.00 - 1.56; P =.05), although this relationship did not persist after further adjustment for fitness (HR, 0.99; 95 % CI, 0.79 - 1.25; P =.95).
The two most popular methods to
measure abdominal obesity and gauge the amount of visceral fat are absolute waist circumference and waist - hip ratio.
Unexpectedly, participants in the highest tertile of sweet food / beverage intake had the highest prevalence of normal weight and lowest prevalence of overweight and obesity as well as the lowest prevalence
of abdominal obesity in men (both P = 0.002; not depicted).
When looking into why a high BMI would reduce the risk of men developing RA in the future, the scientists suggested that a high BMI more often reflects
increased abdominal obesity or visceral fat in men compared with women, which could be protective against the development of RA.
Low levels of vitamin D have been linked to
abdominal obesity.
These findings — published in the June 2014 editions of Molecular Nutrition and Food Research — suggest this ingredient's use as a plausible tool in the comprehensive management of metabolic syndrome (MetS), which is defined as a cluster of heart attack and cardiovascular disease risk factors, including diabetes / prediabetes,
abdominal obesity, dyslipidemia and hypertension.
Bioactive lipids in metabolic syndrome: Scientific literature review on dietary fats and oils that help with decreasing metabolic disorders such as
abdominal obesity, dyslipidemia, hypertension and insulin sensitivity that increase risk of cardiovascular disease.
Some experts believe this may play a direct role in causing the diseases linked to
abdominal obesity.
«Understanding these mechanisms could help health care providers develop new and better interventions to address this population's elevated risk of
abdominal obesity and cardiometabolic risk later in life.»
Researchers also tracked the rise in
abdominal obesity, which is an independent indicator of mortality even among people with normal BMIs.